KENILWORTH, N.J., Nov. 7 Schering-Plough Corporation (NYSE: SGP) will webcast its "R&D Update" meeting for analysts and portfolio managers being held on Monday, Nov. 24, 2008. Fred Hassan, Schering-Plough's chairman and CEO, Tom Koestler, Ph.D., executive vice president and president, Schering-Plough Research Institute, and other members of management will host the meeting. The primary purpose of the meeting is to provide an update on the company's late-stage projects in development and progress with the strategic Action Agenda, including reviews of selected projects and products.
At approximately 8:30 a.m. (EST) on that day, a live audio webcast of the meeting will be available by going to the Investor Relations section of the Schering-Plough corporate Web site, www.schering-plough.com, and clicking on the "Presentations/Webcasts" link. A replay of the webcast will be available starting on Nov. 24 through 5 p.m. on Dec. 24.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
SOURCE Schering-Plough Corporation